skip to Main Content
Phone: 301-655-1084 Email: info@glycomantra.com

GM101 Inhibits Cancer Survival and Resistance Pathways

We are seeking a pharma licensee or co-developer for our first-in-class biologic GM101 which is a Galectin-3 decoy.  Galectin-3 is known to be active in multiple tumorigenic pathways. Suppressing multiple cell proliferation pathways provides our drug candidates and our pico-molar KD provide a clear competitive advantage compared to single action drugs.

Maryland residents are eligible to receive Biotechnology Investment Incentive Tax Credit (BIITC). BIITC provides an income tax credit equal to 50% of an eligible investment up to $250,000 per fiscal year. For more information, see

http://commerce.maryland.gov/fund/programs-for-businesses/bio-tax-credit

 

Contact us
Back To Top